|
| 36633581 | Understanding the Relationship Between Perseveration, Comorbid Behavioral Symptoms, Motor Decline, Functional Decline, and Self-report Accuracy in Huntington Disease Can Help Inform Clinical Practice. | Cogn Behav Neurol | 2023 |
| 37334615 | What Patients Say: Large-Scale Analyses of Replies to the Parkinson's Disease Patient Report of Problems (PD-PROP). | J Parkinsons Dis | 2023 |
| 36607769 | Death Anxiety in Huntington Disease: Longitudinal Heath-Related Quality-of-Life Outcomes. | J Palliat Med | 2023 |
| 36294700 | The Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington's Disease. | J Pers Med | 2022 |
| 36557263 | Alteration of Autophagy and Glial Activity in Nilotinib-Treated Huntington's Disease Patients. | Metabolites | 2022 |
| 36201624 | Somatoform Symptoms in Parkinson Disease. | Cogn Behav Neurol | 2022 |
| 34335433 | Utility of Huntington's Disease Assessments by Disease Stage: Floor/Ceiling Effects. | Front Neurol | 2021 |
| 31093973 | The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study. | Clin Genet | 2019 |
| 31381523 | The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research Participation. | J Huntingtons Dis | 2019 |
| 31296586 | Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia. | J Neurol Neurosurg Psychiatry | 2019 |
| 31594241 | Quality of Care for Huntington's Disease in the United States: Findings from a National Survey of Patients and Caregivers. | J Huntingtons Dis | 2019 |
| 29750428 | Understanding How Chorea Affects Health-Related Quality of Life in Huntington Disease: An Online Survey of Patients and Caregivers in the United States. | Patient | 2018 |
| 32685569 | Retrospective Analysis of Healthcare Resource Use, Treatment Patterns, and Treatment-related Events in Patients with Huntington's Disease-associated Chorea Initiated on Tetrabenazine. | J Health Econ Outcomes Res | 2018 |
| 30040737 | Clinical Management of Neuropsychiatric Symptoms of Huntington Disease: Expert-Based Consensus Guidelines on Agitation, Anxiety, Apathy, Psychosis and Sleep Disorders. | J Huntingtons Dis | 2018 |
| 30198875 | Huntington's Disease and Employment: The Relative Contributions of Cognitive and Motor Decline to the Decision to Leave Work. | J Huntingtons Dis | 2018 |
| 27913695 | A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. | Neurology | 2017 |
| 28256103 | Response to letter by Saenz-Farret et al. on "Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations". | Mov Disord | 2017 |
| 28446646 | Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study. | Neurology | 2017 |
| 28947130 | Preface. | Handb Clin Neurol | 2017 |
| 28668671 | Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial. | Lancet Psychiatry | 2017 |
| 28766071 | Erratum to: Inaugural Conference on Incorporating Patient-Reported Outcomes and Patient Preference Information into Clinical Research, Clinical Care, and Risk-Benefit Assessments for Neurodegenerative Diseases. | Patient | 2017 |
| 28688021 | Inaugural Conference on Incorporating Patient-Reported Outcomes and Patient Preference Information into Clinical Research, Clinical Care, and Risk-Benefit Assessments for Neurodegenerative Diseases. | Patient | 2017 |
| 27380342 | Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. | JAMA | 2016 |
| 30713949 | Are Patients with Psychogenic Movement Disorders More Likely to be Healthcare Workers? | Mov Disord Clin Pract | 2016 |
| 30363395 | Data Analytics from Enroll-HD, a Global Clinical Research Platform for Huntington's Disease. | Mov Disord Clin Pract | 2016 |
| 26472629 | Longitudinal Psychiatric Symptoms in Prodromal Huntington's Disease: A Decade of Data. | Am J Psychiatry | 2016 |
| 27983561 | Risk Factors for Suicidal Ideation in People at Risk for Huntington's Disease. | J Huntingtons Dis | 2016 |
| 27296904 | Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations. | Mov Disord | 2016 |
| 24972974 | Does spouse participation influence quality of life reporting in patients with Parkinson's disease? | Qual Life Res | 2015 |
| 24489384 | Boy will be boys: sex differences in wild infant chimpanzee social interactions. | Anim Behav | 2014 |
| 25575957 | Interventional differences among Huntington's disease patients by disease progression in commercial and medicaid populations. | J Huntingtons Dis | 2014 |
| 24828898 | Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY). | J Neurol Neurosurg Psychiatry | 2014 |
| 24911160 | Sex differences in wild chimpanzee behavior emerge during infancy. | PLoS One | 2014 |
| 22901696 | Figural memory performance and functional magnetic resonance imaging activity across the adult lifespan. | Neurobiol Aging | 2013 |
| 25062735 | Depressed mood and suicidality in individuals exposed to tetrabenazine in a large Huntington disease observational study. | J Huntingtons Dis | 2013 |
| 24275604 | Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety. | J Parkinsons Dis | 2013 |
| 23789925 | The direct medical costs of Huntington's disease by stage. A retrospective commercial and Medicaid claims data analysis. | J Med Econ | 2013 |
| 23567419 | Pharmacologic treatment of anxiety disorders in Parkinson disease. | Am J Geriatr Psychiatry | 2013 |
| 23514630 | Comparison of caregiver strain in Parkinson's disease between Yamagata, Japan, and Maryland, The United States. | Parkinsonism Relat Disord | 2013 |
| 23265679 | Dual task performance in Parkinson's disease: a sensitive predictor of impairment and disability. | Parkinsonism Relat Disord | 2013 |
| 23128427 | Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. | JAMA Neurol | 2013 |
| 21617521 | Prevalence of psychotic symptoms in a community-based Parkinson disease sample. | Am J Geriatr Psychiatry | 2012 |
| 23168090 | Psychogenic seizures and psychogenic movement disorders: are they the same patients? | Epilepsy Behav | 2012 |
| 22422897 | A comparison of nine scales to detect depression in Parkinson disease: which scale to use? | Neurology | 2012 |
| 22343285 | Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. | Proc Natl Acad Sci U S A | 2012 |
| 22079524 | The effects of gait impairment with and without freezing of gait in Parkinson's disease. | Parkinsonism Relat Disord | 2012 |
| 21975263 | What determines resilience in patients with Parkinson's disease? | Parkinsonism Relat Disord | 2012 |
| 21149802 | Racial and socioeconomic disparities in parkinsonism. | Arch Neurol | 2011 |
| 22120841 | Assessment of cognitive symptoms in prodromal and early huntington disease. | PLoS Curr | 2011 |
| 21826116 | Assessing behavioural manifestations prior to clinical diagnosis of huntington disease: "anger and irritability" and "obsessions and compulsions". | PLoS Curr | 2011 |